TMT, biotech fund Oceanpine raises $400 million

After launching in 2016 with GP internal capital, Oceanpine announced a final closing of its Oceanpine Capital Fund II totaling $400 million.
The Beijing-based firm invests . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.